Faster Heart Failure Diagnosis

Dr Vlad Miscianinov began his research career at the University of Sheffield, where he earned a Master of Biological Sciences degree in Genetics. He continued his academic journey in Edinburgh, pursuing his PhD in Cardiovascular Science at the University of Edinburgh Medical School.

Throughout his doctoral studies, Vlad authored and co-authored multiple publications, including a manuscript on the role of microRNA in cardiovascular disease and regeneration, and filed a patent for a microRNA-based wound healing gene therapy.

Following his PhD, Vlad accepted a postdoctoral research fellow position in Professor Andrew Baker’s lab, where he developed a novel lncRNA-based gene therapy approach to prevent vein graft failure in patients undergoing coronary artery bypass surgery.

Throughout his academic career, Vlad developed a keen interest in business, which ultimately led him to establish Biohabit Ltd, where he currently serves as CEO and R&D Director.

Dr John D Hung holds a Medical degree from the University of Liverpool, and he completed his General Cardiology training at Countess of Chester, Aintree, and Royal Liverpool Hospital. He subsequently pursued a PhD at the University of Edinburgh, where he investigated the role of lncRNA in human atherosclerosis.

In parallel, John served as a Cardiology Research Fellow and studied atherosclerosis using MRI and intravascular imaging. John has co-authored 15 research publications, highlighting his commitment to the field.

Currently, John serves as a Consultant Cardiologist in Interventional Cardiology at Liverpool Heart and Chest Hospital, where he was recently promoted.

He also co-founded Biohabit Ltd and serves as the Medical Director, where he combines his medical practice with his passion for developing breakthrough solutions in the field of precision and personalised medicine.